Sanofi-Avantis vaccine division Sanofi Pasteur‘s pandemic influenza vaccine Emerflu has been approved by the Australian Therapeutic Goods Administration (TGA).

The vaccine will be manufactured and distributed with the identified pandemic strain and used in Australia in accordance with official Australian government guidance.